Pathogenesis of Prediabetes: Role of the Liver in Isolated Fasting Hyperglycemia and Combined Fasting and Postprandial Hyperglycemia
Overview
Affiliations
Context: People with prediabetes are at high risk of developing diabetes.
Objective: The objective of this study was to determine the pathogenesis of fasting and postprandial hyperglycemia in prediabetes.
Design: Glucose production, gluconeogenesis, glycogenolysis, and glucose disappearance were measured before and during a hyperinsulinemic clamp using [6,6-(2)H2]glucose and the deuterated water method corrected for transaldolase exchange.
Setting: The study was conducted at the Mayo Clinic Clinical Research Unit.
Participants: Subjects with impaired fasting glucose (IFG)/normal glucose tolerance (NGT) (n = 14), IFG/impaired glucose tolerance (IGT) (n = 18), and normal fasting glucose (NFG)/NGT (n = 16) were studied.
Intervention: A hyperinsulinemic clamp was used.
Outcome Measures: Glucose production, glucose disappearance, gluconeogenesis, and glycogenolysis were measured.
Results: Fasting glucose production was higher (P < .0001) in subjects with IFG/NGT than in those with NFG/NGT because of increased rates of gluconeogenesis (P = .003). On the other hand, insulin-induced suppression of glucose production, gluconeogenesis, glycogenolysis, and stimulation of glucose disappearance all were normal. Although fasting glucose production also was increased (P = .0002) in subjects with IFG/IGT, insulin-induced suppression of glucose production, gluconeogenesis, and glycogenolysis and stimulation of glucose disappearance were impaired (P = .005).
Conclusions: Fasting hyperglycemia is due to excessive glucose production in people with either IFG/NGT or IFG/IGT. Both insulin action and postprandial glucose concentrations are normal in IFG/NGT but abnormal in IFG/IGT. This finding suggests that hepatic and extrahepatic insulin resistance causes or exacerbates postprandial glucose intolerance in IFG/IGT. Elevated gluconeogenesis in the fasting state in IFG/NGT and impaired insulin-induced suppression of both gluconeogenesis and glycogenolysis in IFG/IGT suggest that alteration in the regulation of these pathways occurs early in the evolution of type 2 diabetes.
Bahadoran Z, Kashani Z, Mahdavi M, Mirmiran P, Azizi F Eur J Med Res. 2025; 30(1):110.
PMID: 39962610 PMC: 11834172. DOI: 10.1186/s40001-025-02337-5.
Dwibedi C, Axelsson A, Abrahamsson B, Fahey J, Asplund O, Hansson O Nat Microbiol. 2025; 10(3):681-693.
PMID: 39929977 PMC: 11879859. DOI: 10.1038/s41564-025-01932-w.
Non-catalytic mechanisms of KMT5C regulating hepatic gluconeogenesis.
Zhao Q, Cui X, Zhu Q, Li F, Bao R, Shi T Nat Commun. 2025; 16(1):1483.
PMID: 39929827 PMC: 11811016. DOI: 10.1038/s41467-025-56696-y.
Kabeer S, Sharma S, Sriramdasu S, Tikoo K Biol Res. 2024; 57(1):27.
PMID: 38745315 PMC: 11092102. DOI: 10.1186/s40659-024-00495-0.
NADPH Oxidase 3: Beyond the Inner Ear.
Herb M Antioxidants (Basel). 2024; 13(2).
PMID: 38397817 PMC: 10886416. DOI: 10.3390/antiox13020219.